Deltacma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 4164.44%
- Profit Growth -376.08%
- Ebitda -379.84%
- Net Worth -480.14%
- Total Assets 619.14%
About Deltacma
Deltacma Private Limited (DPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2021 (Three years and ten months 22 days old ). Its registered office is in Delhi, India.
The Corporate was formerly known as Detlacma Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299DL2021PTC378442
-
Company No.
378442
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Deltacma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vidit Jain
|
Director | 12-Mar-2021 | Current |
|
Radhika Ghai
|
Director | 12-Mar-2021 | Current |
Financial Performance of Deltacma.
Deltacma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4164.44% increase. The company also saw a substantial fall in profitability, with a 376.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 480.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deltacma?
In 2023, Deltacma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Zetacma Private LimitedVidit Jain and Radhika Ghai are mutual person
-
Alphacma Private Limited
Vidit Jain and Radhika Ghai are mutual person
-
Vap Medcare Private Limited
Vidit Jain is a mutual person
-
Thetacma Ventures Llp
Radhika Ghai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Deltacma?
Deltacma has a workforce of 25 employees as of Sep 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deltacma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deltacma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.